Esquer Flores J, Orea Solano M, Gálvez Gudiño V J
Alergia e inmunología clínica, H.R. 20 de Noviembre, ISSSTE.
Rev Alerg. 1991 Sep-Oct;38(5):131-3.
Fifteen patients diagnosed with bronchial asthma were examined to evaluate the cardiotoxicity caused by the combined intravenous treatment using methylxanthine-aminophylline 250 mg and a beta agonist: salbutamol 0.5 mg. The following observations were made: four patients had sinus tachycardia and another suffered from ventricular extrasystoles as seen in the electrocardiographic register; another two patients had sinus tachycardia when the bronchial dilator dosage was doubled. From a clinical and electrocardiographic standpoint, arrhythmias do not seem to be a grave problem among the population studied.